{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=CNS+Vasculitis", "query": { "condition": "CNS Vasculitis" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 74, "total_pages": 8, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=CNS+Vasculitis&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-06-10T10:15:38.713Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT07138898", "title": "Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Rheumatic Disease" ], "interventions": [ { "name": "Methotrexate", "type": "DRUG" }, { "name": "Sulfasalazine", "type": "DRUG" }, { "name": "Hydroxychloroquine", "type": "DRUG" }, { "name": "Leflunomide", "type": "DRUG" }, { "name": "Azathioprine", "type": "DRUG" }, { "name": "Mycophenolate", "type": "DRUG" }, { "name": "Cyclosporine", "type": "DRUG" }, { "name": "Tacrolimus", "type": "DRUG" }, { "name": "Etanercept", "type": "DRUG" }, { "name": "Adalimumab", "type": "DRUG" }, { "name": "Golimumab", "type": "DRUG" }, { "name": "Certolizumab", "type": "DRUG" }, { "name": "Infliximab", "type": "DRUG" }, { "name": "Rituximab", "type": "BIOLOGICAL" }, { "name": "Belimumab", "type": "BIOLOGICAL" }, { "name": "Tocilizumab", "type": "BIOLOGICAL" }, { "name": "Anakinra", "type": "BIOLOGICAL" }, { "name": "Canakinumab", "type": "BIOLOGICAL" }, { "name": "Abatacept", "type": "BIOLOGICAL" }, { "name": "Secukinumab", "type": "BIOLOGICAL" }, { "name": "Ixekizumab", "type": "BIOLOGICAL" }, { "name": "Bimekizumab", "type": "BIOLOGICAL" }, { "name": "Ustekinumab", "type": "BIOLOGICAL" }, { "name": "Guselkumab", "type": "BIOLOGICAL" }, { "name": "Risankizumab", "type": "BIOLOGICAL" }, { "name": "Tofacitinib", "type": "DRUG" }, { "name": "Upadacitinib", "type": "DRUG" } ], "intervention_types": [ "DRUG", "BIOLOGICAL" ], "sponsor": "NYU Langone Health", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 80, "start_date": "2025-09", "completion_date": "2027-09", "has_results": false, "last_update_posted_date": "2025-08-24", "last_synced_at": "2026-06-10T10:15:38.713Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT07138898" }, { "nct_id": "NCT02190929", "title": "Educational Needs of Patients With Systemic Vasculitis", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Behcet's Disease", "Churg-Strauss Syndrome", "Vasculitis, Central Nervous System", "Giant Cell Arteritis", "Wegener Granulomatosis", "Henoch-Schoenlein Purpura", "Microscopic Polyangiitis", "Polyarteritis Nodosa", "Takayasu's Arteritis" ], "interventions": [], "intervention_types": [], "sponsor": "University of South Florida", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 386, "start_date": "2012-03", "completion_date": "2014-02", "has_results": false, "last_update_posted_date": "2014-07-15", "last_synced_at": "2026-06-10T10:15:38.713Z", "location_count": 1, "location_summary": "Tampa, Florida", "locations": [ { "city": "Tampa", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02190929" }, { "nct_id": "NCT02006134", "title": "Pediatric Vasculitis Initiative", "overall_status": "UNKNOWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Wegeners Granulomatosis (Granulomatosis With Polyangiitis)", "Microscopic Polyangiitis", "Eosinophilic Granulomatosis With Polyangiitis", "Polyarteritis Nodosa", "Takayasu Arteritis", "Primary CNS Vasculitis", "Unclassified Vasculitis" ], "interventions": [], "intervention_types": [], "sponsor": "University of British Columbia", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": null, "maximum_age": "20 Years", "sex": "ALL", "summary": "Up to 20 Years" }, "enrollment_count": 1600, "start_date": "2013-01", "completion_date": "2025-03", "has_results": false, "last_update_posted_date": "2023-11-30", "last_synced_at": "2026-06-10T10:15:38.713Z", "location_count": 10, "location_summary": "San Francisco, California • Gainesville, Florida • Chicago, Illinois + 7 more", "locations": [ { "city": "San Francisco", "state": "California" }, { "city": "Gainesville", "state": "Florida" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Indianapolis", "state": "Indiana" }, { "city": "Hackensack", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT02006134" }, { "nct_id": "NCT00006055", "title": "Autologous Peripheral Blood Stem Cell Transplantation in Patients With Life Threatening Autoimmune Diseases", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Purpura, Schoenlein-Henoch", "Graft Versus Host Disease", "Anemia, Hemolytic, Autoimmune", "Rheumatoid Arthritis", "Churg-Strauss Syndrome", "Hypersensitivity Vasculitis", "Wegener's Granulomatosis", "Systemic Lupus Erythematosus", "Giant Cell Arteritis", "Pure Red Cell Aplasia", "Juvenile Rheumatoid Arthritis", "Polyarteritis Nodosa", "Autoimmune Thrombocytopenic Purpura", "Takayasu Arteritis" ], "interventions": [ { "name": "anti-thymocyte globulin", "type": "DRUG" }, { "name": "cyclophosphamide", "type": "DRUG" }, { "name": "cyclosporine", "type": "DRUG" }, { "name": "filgrastim", "type": "DRUG" }, { "name": "methylprednisolone", "type": "DRUG" }, { "name": "prednisone", "type": "DRUG" }, { "name": "Autologous Peripheral Blood Stem Cell Transplantation", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "PROCEDURE" ], "sponsor": "Fairview University Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Year", "maximum_age": "55 Years", "sex": "ALL", "summary": "1 Year to 55 Years" }, "enrollment_count": 10, "start_date": "2000-03", "completion_date": null, "has_results": false, "last_update_posted_date": "2005-06-24", "last_synced_at": "2026-06-10T10:15:38.713Z", "location_count": 1, "location_summary": "Minneapolis, Minnesota", "locations": [ { "city": "Minneapolis", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT00006055" }, { "nct_id": "NCT03166319", "title": "Vessel Wall Imaging for Diagnosis and Monitoring of Central Nervous System (CNS) Vasculitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Vasculitis, CNS", "Vasculitis, Cerebral" ], "interventions": [ { "name": "MRI, including intracranial vessel wall imaging", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 15, "start_date": "2017-07-24", "completion_date": "2020-11-24", "has_results": false, "last_update_posted_date": "2022-03-17", "last_synced_at": "2026-06-10T10:15:38.713Z", "location_count": 1, "location_summary": "Rochester, Minnesota", "locations": [ { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT03166319" }, { "nct_id": "NCT03712345", "title": "Safety and Efficacy Study of IFX-1 in add-on to Standard of Care in GPA and MPA", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Granulomatosis With Polyangiitis (GPA)", "Microscopic Polyangiitis (MPA)" ], "interventions": [ { "name": "IFX-1 low dose", "type": "DRUG" }, { "name": "IFX-1 high dose", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "InflaRx GmbH", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 20, "start_date": "2018-10-15", "completion_date": "2021-05-03", "has_results": true, "last_update_posted_date": "2022-05-26", "last_synced_at": "2026-06-10T10:15:38.713Z", "location_count": 33, "location_summary": "Scottsdale, Arizona • Loma Linda, California • Doral, Florida + 30 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Loma Linda", "state": "California" }, { "city": "Doral", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT03712345" }, { "nct_id": "NCT03941184", "title": "Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "SCAD", "Addison Disease", "Ankylosing Spondylitis", "Antiphospholipid Antibody Syndrome", "Celiac Disease", "Crohn Disease", "Dermatomyositis", "Polymyositis", "Guillain-Barre Syndrome", "Hepatitis, Autoimmune", "Graves Disease", "Hashimoto Thyroiditis", "Multiple Sclerosis", "Myasthenia Gravis", "Pernicious Anemia", "Polymyalgia Rheumatica", "Primary Biliary Cirrhosis", "Psoriasis", "Rheumatoid Arthritis", "Systemic Sclerosis", "Sjögren Syndrome", "Systemic Lupus Erythematosus", "Takayasu Arteritis", "Type 1 Diabetes Mellitus", "Ulcerative Colitis", "Uveitis", "Vasculitis", "Vitiligo", "Raynaud" ], "interventions": [], "intervention_types": [], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": null, "eligibility": { "minimum_age": "18 Years", "maximum_age": "110 Years", "sex": "ALL", "summary": "18 Years to 110 Years" }, "enrollment_count": 114, "start_date": "1995-01-01", "completion_date": "2020-11-10", "has_results": false, "last_update_posted_date": "2020-11-23", "last_synced_at": "2026-06-10T10:15:38.713Z", "location_count": 1, "location_summary": "Rochester, Minnesota", "locations": [ { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT03941184" }, { "nct_id": "NCT01613599", "title": "An Observational Study of The Safety of MabThera/Rituxan (Rituximab) in Participants With Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Granulomatosis With Polyangiitis", "Microscopic Polyangiitis" ], "interventions": [ { "name": "Rituximab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Genentech, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 100, "start_date": "2012-06-20", "completion_date": "2017-04-28", "has_results": true, "last_update_posted_date": "2018-07-26", "last_synced_at": "2026-06-10T10:15:38.713Z", "location_count": 15, "location_summary": "Scottsdale, Arizona • Los Angeles, California • Jacksonville, Florida + 11 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT01613599" }, { "nct_id": "NCT01456416", "title": "Glatiramer Acetate for Multiple Sclerosis With Autoimmune Comorbidities", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Relapsing Remitting Multiple Sclerosis" ], "interventions": [], "intervention_types": [], "sponsor": "University of Southern California", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 10, "start_date": "2011-09", "completion_date": "2013-04", "has_results": false, "last_update_posted_date": "2013-04-04", "last_synced_at": "2026-06-10T10:15:38.713Z", "location_count": 1, "location_summary": "Los Angeles, California", "locations": [ { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01456416" }, { "nct_id": "NCT02084147", "title": "PET-MRI in Diagnosing Patients With Cancer, Cardiac Diseases, or Neurologic Diseases", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Cardiac Disease", "Dementia", "Inflammatory Disease", "Fever of Unknown Origin", "Vasculitis", "Osteomyelitis", "FDG Avid Cancers" ], "interventions": [ { "name": "positron emission tomography", "type": "DEVICE" }, { "name": "computed tomography", "type": "DEVICE" }, { "name": "magnetic resonance imaging", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Case Comprehensive Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 72, "start_date": "2013-03-07", "completion_date": "2018-10-02", "has_results": true, "last_update_posted_date": "2019-10-29", "last_synced_at": "2026-06-10T10:15:38.713Z", "location_count": 1, "location_summary": "Cleveland, Ohio", "locations": [ { "city": "Cleveland", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT02084147" } ] }